A multicenter observational study in Japan published in the Frontiers in Clinical Diabetes and Healthcare found that individuals with type 2 diabetes taking glucagon-like peptide-1 receptor agonists (GLP-1RAs) showed reduced external eating scores after 12 months of therapy Their blood sugar levels, body weight, and body fat percentage also decreased significantly Emotional and restrained eating showed only transient changes
By stimulating glutathione levels, it has a positive effect on insulin secretion and increases insulin sensitivity, so it can be used as an adjunct in the treatment of insulin-resistant conditions in polycystic ovary syndrome, which is closely related to insulin resistance (13)
Intracellular trafficking may also be facilitated by intestinal bile acid binding protein, guiding the conjugate within the cytosol
Toxic chemicals are primarily metabolized in your liver (2)
It does have a balanced mix of sodium, carbohydrates, and sugars, making it a good option for rehydration outside of intensive exercise
Can you microdose GLP-1s safely